FGFR1 and gastric cancer: Currently, several types of FGFR-targeting drugs have been explored or developed for GC, including multi-kinase inhibitors, pan-FGFR inhibitors, FGFR1-3 inhibitors, selective FGFR inhibitors, and ADC (Guan et al. 2023).